Member Info for JOHNO77

NIce start, looks like it could be the day we head out of this range once and for all!?!?

Very interesting thanks Vander, that Sept 2015 update reads mouth wateringly well.. An update similar to that would be very nice indeed.

Milestone payments potentially totalling $126m for the 1st product and up to $93M for each subsequent qualifying product.

Tiered royalties on net sales plus all development and commercialisation costs funded by AZN.

The 20th Dec RNS.

Any one else think this is a case of N4 getting their house in order at the request of Medimmune prior to a deal being made?

Extension opens up N4 to so many new avenues, particularly the dual therapy cancer approach. Med would not want to strike a deal without this all being in place 1st.

I don’t think AZN will have any problems with the manufacturing

I've positioned for a Medimmune deal....If it comes off then it's ££££'s happy days. If its a no go then c'est la vie...

AGL had a nice rns late today, pharma's moving quick on news at the mo...

Bring it on MedImmune. You hope that if Med' did not want to proceed with N4 then they would have established that long ago (prob' after the 9 month period) and it would have been rns'ed already. The fact that they are still with us surely indicates that they are very keen on the tech. At this stage surely it is just a case of the big wigs at Med getting together and deciding how much they are willing to pay to keep using our tech? Hopefully we'll find out soon.

GLA

HNY all. Nice end to the week, let’s see what this week brings. Many expecting news this month. Could a blue January a la 2018 be on the cards???

If that was the case the decision has already been made and the paperwork being typed up. They may still work between Xmas and new yr but you would think most of the key decision makers will be at home enjoying themselves!

Oooh good spot maybe there is hope for 2017 after all. Lol to be honest we’ve waiting a long time now, another 30 odd days is no problem for me anyway.

Considering there's only about 3 days left before next year Apple, I'd hazard a guess at news in the new year.

Although positive news, people expected that sort of thing to already be in place which is IMO why people are indifferent to it.... Powderpuff rise this morning on powderpuff volume always going to bring sells from anyone with short terms trades open.

Most here are just waiting for the big one to come through, everything else is just noise for now....

Baggy, N4P are the ones with the exclusive global licence for the commercialisation of Nuvec® Uniquest only have the license for the bits N4 have no commercial interest in.

Opens Nuvec up to many additional applications it seems. Using Nuvec to more effectively target cancerous cells seems to be mentioned increasingly by the company.

Still here bob...... Quietly waiting in background.

Thanks Waccy interesting article, shows what a groundbreaking space N4P are trying to grab a hold of. Nanotechnology is clearly the future for more efficient and targeted drug delivery.

Back in the teens will be nice. Looks like we could have seen the last of 8/9p.

Great update should be another good day here

Well said Vander /DJ

Yep looking good guys :)

Lol. Very happy for multinationals to be sniffing around this AIM tiddler. That is what’s it’s all about. No delays with the AZN timeline, all going to plan.

This is outside of the medimmune work Bidnolid A commercial deal with AZN could come at any time as per collab RNS